Lonza and BioWa sign license agreements with Pfizer
06:28 AM | July 30, 2013 | Deepti Ramesh
Lonza and BioWa (La Jolla, CA), a wholly owned subsidiary of biopharmaceutical company Kyowa Hakko Kirin (Tokyo), have entered into research agreements with Pfizer allowing the use of the Potelligent...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.